Pacer Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.98M | Sell |
337,667
-81,409
| -19% | -$2.41M | 0.02% | 483 |
|
|
2025
Q1 | $12.5M | Sell |
419,076
-1,723,415
| -80% | -$51.4M | 0.03% | 413 |
|
|
2024
Q4 | $61.4M | Sell |
2,142,491
-447,157
| -17% | -$12.8M | 0.13% | 172 |
|
|
2024
Q3 | $100M | Sell |
2,589,648
-818,721
| -24% | -$31.6M | 0.21% | 129 |
|
|
2024
Q2 | $110M | Buy |
3,408,369
+821,541
| +32% | +$26.5M | 0.25% | 118 |
|
|
2024
Q1 | $100M | Buy |
2,586,828
+412,110
| +19% | +$16M | 0.23% | 121 |
|
|
2023
Q4 | $66.9M | Buy |
2,174,718
+883,380
| +68% | +$27.2M | 0.19% | 134 |
|
|
2023
Q3 | $28.9M | Buy |
1,291,338
+511,692
| +66% | +$11.4M | 0.11% | 191 |
|
|
2023
Q2 | $16.8M | Buy |
779,646
+336,879
| +76% | +$7.24M | 0.07% | 267 |
|
|
2023
Q1 | $10.6M | Buy |
442,767
+141,458
| +47% | +$3.39M | 0.05% | 381 |
|
|
2022
Q4 | $6.99M | Buy |
+301,309
| New | +$6.99M | 0.04% | 383 |
|
|
2022
Q2 | – | Sell |
-220,982
| Closed | -$4.5M | – | 2393 |
|
|
2022
Q1 | $4.5M | Buy |
220,982
+75,090
| +51% | +$1.53M | 0.04% | 446 |
|
|
2021
Q4 | $2.73M | Buy |
145,892
+39,558
| +37% | +$739K | 0.03% | 680 |
|
|
2021
Q3 | $2.1M | Buy |
106,334
+15,932
| +18% | +$314K | 0.03% | 647 |
|
|
2021
Q2 | $2.14M | Buy |
+90,402
| New | +$2.14M | 0.03% | 602 |
|